Delving into the Latest Updates on Herpes zoster virus mRNA vaccines(Beijing Kexing Zhongwei ) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine, mRNA vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious Diseases

Active Indication

Herpes Zoster

Inactive Indication-

Originator Organization

Beijing Kexing Zhongwei Biotechnology Co. Ltd.

Active Organization

Beijing Kexing Zhongwei Biotechnology Co. Ltd.

Sinovac Biotech Co. Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

This clinical trial included two parts, Part A and Part B. The goal of Part A is to evaluate the safety and preliminary immunogenicity of the lyophilized herpes zoster virus mRNA vaccine (HZ mRNA vaccine) in healthy populations aged 40 years and older. The goal of Part B is to select the optimal dosage and schedule in healthy populations aged 50 years and older to support next further study.

Start Date06 Jan 2026

Sponsor / Collaborator

Sinovac Biotech Co. Ltd.

CTR20254939

/ Not yet recruitingPhase 1/2

评价不同剂量冻干带状疱疹病毒mRNA疫苗用于40岁及以上人群安全性和免疫原性的随机、双盲、对照I/Ⅱ期临床试验

[Translation] A randomized, double-blind, controlled phase I/II clinical trial evaluating the safety and immunogenicity of different doses of lyophilized herpes zoster virus mRNA vaccines in patients aged 40 years and older.

主要目的是评价试验疫苗的安全性和有效性

[Translation]

The primary objective is to evaluate the safety and efficacy of the experimental vaccine.

Start Date-

Sponsor / Collaborator

Beijing Kexing Zhongwei Biotechnology Co. Ltd.

100 Clinical Results associated with Herpes zoster virus mRNA vaccines(Beijing Kexing Zhongwei )

Login to view more data

100 Translational Medicine associated with Herpes zoster virus mRNA vaccines(Beijing Kexing Zhongwei )

Login to view more data

100 Patents (Medical) associated with Herpes zoster virus mRNA vaccines(Beijing Kexing Zhongwei )

Login to view more data